Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

K. Kalinsky, J. A. Sparano, X. Zhong, E. Andreopoulou, B. Taback, L. Wiechmann, S. M. Feldman, P. Ananthakrishnan, A. Ahmad, S. Cremers, A. N. Sireci, J. R. Cross, D. K. Marks, P. Mundi, E. Connolly, K. D. Crew, M. A. Maurer, H. Hibshoosh, S. Lee, D. L. Hershman

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial'. Together they form a unique fingerprint.

Medicine & Life Sciences